Aspire Growth Partners Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$1.23M |
| 2 |
Invesco NASDAQ 100 ETF
QQQM
|
+$1.13M |
| 3 |
Vanguard S&P 500 Value ETF
VOOV
|
+$843K |
| 4 |
Capital Group Core Equity ETF
CGUS
|
+$521K |
| 5 |
Meta Platforms (Facebook)
META
|
+$368K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoetis
ZTS
|
+$542K |
| 2 |
Steris
STE
|
+$464K |
| 3 |
Comcast
CMCSA
|
+$251K |
| 4 |
Marathon Petroleum
MPC
|
+$245K |
| 5 |
Chevron
CVX
|
+$244K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 51.33% |
| 2 | Technology | 17.71% |
| 3 | Industrials | 5.84% |
| 4 | Financials | 5.04% |
| 5 | Communication Services | 4.62% |
Similar funds
Aspire Growth Partners's Q2 2026 Portfolio in Review
As of Q2 2026, Aspire Growth Partners held 135 positions worth $172M, up 18% from $146M the previous quarter. Its ten largest holdings account for 50% of the portfolio.
Aspire Growth Partners deployed $7.14M of net new capital in Q2 2026, opening 14 new positions and adding to 66 existing holdings. Its largest new stake was Edwards Lifesciences: 3,963 shares worth $358K.
By sector, the portfolio is most concentrated in Miscellaneous at 51% of assets, up from 49% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was Marathon Petroleum, an estimated $245K trimmed.
- Aspire Growth Partners's largest Q2 2026 buy was Edwards Lifesciences: 3,963 shares worth $358K.
- Aspire Growth Partners added most to Vanguard S&P 500 ETF in Q2 2026, an estimated $1.23M increase.
- Aspire Growth Partners's biggest Q2 2026 reduction was Marathon Petroleum, cutting an estimated $245K.
- Aspire Growth Partners fully exited Zoetis in Q2 2026, selling an estimated $542K.
- Aspire Growth Partners's ten largest holdings make up 50% of its $172M portfolio in Q2 2026.
- Aspire Growth Partners opened 14 new positions and closed 7 in Q2 2026.
- Aspire Growth Partners's portfolio value rose 18% quarter-over-quarter to $172M.
Based on Aspire Growth Partners's 13F filing for Q2 2026, filed 29 Jul 2026.